drugset / Trial / NCT03111121
Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy
RandomizedParallel-groupSingle-blindTreatment
Summary
Use of Muscle relaxant and reversal with Sugammadex at end of airway procedures will reduce the time to extubation after end of procedure
Timeline
- Start
- 2017-05-04
- Primary completion
- 2018-06-22
- Completion
- 2019-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glycopyrrolate | Small molecule | 0.01 mg/kg | — |
| Comparator | Neostigmine | Other / unclassified | 0.04 mg/kg | — |
| Comparator | Sugammadex | Other / unclassified | 4 mg/kg | — |
Indications
No indication recorded.